Similar articles

• 5-(N-ethyl-N-isopropyl)-amiloride enhances SMN2 exon 7 inclusion and protein expression in spinal muscular atrophy cells.

  Yuo CY, Lin HH, Chang YS, Yang WK, Chang JG. Yuo CY, et al. Ann Neurol. 2008 Jan;63(1):26-34. doi: 10.1002/ana.21241. Ann Neurol. 2008. PMID: 17924536
• Correction of SMN2 Pre-mRNA splicing by antisense U7 small nuclear RNAs.

  Madocsai C, Lim SR, Geib T, Lam BJ, Hertel KJ. Madocsai C, et al. Mol Ther. 2005 Dec;12(6):1013-22. doi: 10.1016/j.ymthe.2005.08.022. Epub 2005 Oct 14. Mol Ther. 2005. PMID: 16226920
• New splicing mechanism may guide the way to therapy for SMA.

  Foggo V. Foggo V. Lancet Neurol. 2003 Aug;2(8):455. doi: 10.1016/s1474-4422(03)00471-x. Lancet Neurol. 2003. PMID: 15320347 No abstract available.
• Fishing for a mechanism: using zebrafish to understand spinal muscular atrophy.

  Beattie CE, Carrel TL, McWhorter ML. Beattie CE, et al. J Child Neurol. 2007 Aug;22(8):995-1003. doi: 10.1177/0883073807305671. J Child Neurol. 2007. PMID: 17761655 Review.
• Therapeutics development for spinal muscular atrophy.

  Sumner CJ. Sumner CJ. NeuroRx. 2006 Apr;3(2):235-45. doi: 10.1016/j.nurx.2006.01.010. NeuroRx. 2006. PMID: 16554261 Free PMC article. Review.